Report of the board of directors of the universal pharmaceuticals

company.

Executive summary

The meeting had the purpose of improving the image of the company and
launching a new product to the market to recover credibility with consumers,
because in recent weeks the company had problems with a medication for the
treatment of asthma which resulted in harmful side effects and was removed
from the market. Currently, the administration of UP will face three ethical
dilemmas that must be debated and resolved according to the best interests
of the company. The first ethical dilemma refers to a new drug that could
benefit poor people in Africa. The second is about a medication for heart
problems and the third is a medication to lose weight.
Introduction
We are a company which is deciding on a medicine that will help our company
to progress and people to cure them. In this report we are going to talk about
the px200 medicine which we have chosen that is a medicine that helps to
cure heart diseases, Later we will explain how this medicine works, what
benefits it has and what effects it could have on patients. Take into account
that we are a company that will focus on those patients who can cure this
disease and that they can acquire it without being such an expensive product
and get it out on time. Also above all we are a company with ethics, principles
and values that we are aware that we should not put at risk the life of any
patient.
Findings
1. - The first medication is the blindness of the rivers, it is to treat a disease
that causes blindness. The blindness of the rivers is expensive and takes a
long time to make it, probably takes about 10 years to reach the market.
2. - the second drug Px 200 helps treat heart disease. After performing tests
results disappointing. Because in some patients they experienced severe
breathing difficulties and other side effects after taking the medication.
3. - The last drug that makes dieting helps you lose weight. This medication
is unethical because it uses animals to test the medication, and the company
is ethical so it is not possible for you to use animals to experiment because
there are many cases where animals get sick or die.
Conclusion
 In conclusión, the company should decide if they will put principies
before as they claim to be an ethical company beasing in mind that is
not a charily company and their products bring profits as well.
 PX200 to find out the season for side effects and if it connected with
some others drugs or other diseases oh their patients when have
experienced them. The product will be launched with special provisions
in the leaflet.

Recommendation:
We should invest in drugs that comply with principles and profits, so that in
this way you can be a company that handles your drugs ethically.

Research and development director

19/JUNIO/201.